Dr. Reddy's Laboratories announces the launch of Metaxalone Tablets
06 September 2017 | News
The Skelaxin brand and generic had U.S. sales of approximately $139 million MAT for the most recent twelve months ending in July 2017 according to IMS Health
Source: Pixabay
Dr. Reddy’s Laboratories Ltd. has announced the launch Metaxalone Tablets, USP 800 mg which is a therapeutic equivalent generic version of Skelaxin (metaxalone) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
The Skelaxin brand and generic had U.S. sales of approximately $139 million MAT for the most recent twelve months ending in July 2017 according to IMS Health.
Dr. Reddy’s Metaxalone Tablets, USP 800 mg are available in the bottle count size of 100. Skelaxin is a trademark of King Pharmaceuticals Research and Development, Inc
